Idenix Pharmaceuticals to Present at the Third Annual JMP Securities Healthcare Focus Conference.
CAMBRIDGE, Mass., Sept. 29 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. announced today that Idenix management will present a corporate overview at the 2008 Third Annual JMP JMP Jump
JMP Java Memory Profiler
JMP Joint Manpower Program
JMP Joint Management Plan
JMP Joint Marketing Program
JMP JCL Manipulation Program
JMP Joint Mission Planning (US DoD)
JMP Joint Military Program Securities Healthcare Focus Conference on Monday, October 6, 2008 at 4:00 p.m. ET at Le Parker Meridien in Manhattan.
The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com/. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replays will be available on the Idenix website for weeks following the conference.
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus
Idenix Pharmaceuticals Contacts: Amy Sullivan 617-995-9838 (investors) Teri Dahlman 617-995-9905 (media)
CONTACT: Amy Sullivan, investors, +1-617-995-9838, or Teri Dahlman, media, +1-617-995-9905, both of Idenix Pharmaceuticals, Inc.
Web site: http://www.idenix.com/